Haoxi Health Technology Ltd Financial Summary

Quick Answer

Haoxi Health Technology Ltd reported Total Revenue of $32.80 million for fiscal year 2025.

Haoxi Health Technology Ltd — Key Financials by Year

Metric 2025 2024 2023 2022 2021
Total Revenue $32.80M
-32.4%
$48.52M
+71.9%
$28.23M
+74.7%
$16.16M
Net Income $3.88M
+200.1%
$1.29M
+33.2%
$969.8K
+296.5%
$244.6K
Diluted EPS $1.32
+24.5%
$1.06
+21.8%
$0.87
+8600.0%
$0.01
Total Assets $21.60M
+39.3%
$15.51M
+247.4%
$4.46M
Cash and Equivalents $6.66M
+453.2%
$1.20M
Long-Term Debt $301.7K
+21.1%
$249.1K
Stockholders Equity $17.38M
+54.2%
$11.27M
+619.6%
$1.57M
+206.9%
-$1.47M
+24.1%
-$1.93M
R&D Expense $79.5K
-0.6%
$80.0K
+37.5%
$58.2K
-43.3%
$102.5K
Operating Income -$2.00M
-216.5%
$1.72M
+43.6%
$1.20M
+344.9%
$268.8K
Gross Profit $927.8K
-66.3%
$2.75M
+33.4%
$2.06M
+217.9%
$648.7K
  • Haoxi Health Technology Ltd reported Total Revenue of $32.80 million for fiscal year 2025.
  • Haoxi Health Technology Ltd showed a decrease of -32.4% in Total Revenue compared to the prior fiscal year.
  • Haoxi Health Technology Ltd reported Net Income of $3.88 million for fiscal year 2025.
  • Haoxi Health Technology Ltd showed an increase of +200.1% in Net Income compared to the prior fiscal year.
  • Haoxi Health Technology Ltd reported Diluted EPS of $1.32 per share for fiscal year 2025.
  • Haoxi Health Technology Ltd showed an increase of +24.5% in Diluted EPS compared to the prior fiscal year.
  • Haoxi Health Technology Ltd reported Total Assets of $21.60 million for fiscal year 2025.
  • Haoxi Health Technology Ltd showed an increase of +39.3% in Total Assets compared to the prior fiscal year.
  • Haoxi Health Technology Ltd reported Cash and Equivalents of $6.66 million for fiscal year 2024.
  • Haoxi Health Technology Ltd showed an increase of +453.2% in Cash and Equivalents compared to the prior fiscal year.
  • Haoxi Health Technology Ltd reported Long-Term Debt of $301.7 thousand for fiscal year 2024.
  • Haoxi Health Technology Ltd showed an increase of +21.1% in Long-Term Debt compared to the prior fiscal year.
  • Haoxi Health Technology Ltd reported Stockholders Equity of $17.38 million for fiscal year 2025.
  • Haoxi Health Technology Ltd showed an increase of +54.2% in Stockholders Equity compared to the prior fiscal year.
  • Haoxi Health Technology Ltd reported R&D Expense of $79.5 thousand for fiscal year 2025.
  • Haoxi Health Technology Ltd showed a decrease of -0.6% in R&D Expense compared to the prior fiscal year.
  • Haoxi Health Technology Ltd reported Operating Income of -$2.00 million for fiscal year 2025.
  • Haoxi Health Technology Ltd showed a decrease of -216.5% in Operating Income compared to the prior fiscal year.
  • Haoxi Health Technology Ltd reported Gross Profit of $927.8 thousand for fiscal year 2025.
  • Haoxi Health Technology Ltd showed a decrease of -66.3% in Gross Profit compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment